Pasithea Clinics Is Flipping the Script on Treatment-Resistant Psychiatric Conditions

variety.com:

Kathleen Frazier Considering that one in four adults in the U.S. experience mental illness each year and that suicide is the second leading cause of death among people age 10-34, everyone has a responsibility to advocate for mental health.

May 21 is Mental Health Awareness Day, and the entertainment industry has done its part to raise awareness, producing more and more work that addresses mental health challenges. “The Fallout,” “A Star Is Born” and “13 Reasons Why” are a few examples.Such media narratives are key to starting conversations and educating the public.Unfortunately, about a third of patients with psychiatric conditions do not have an adequate response to first-line antidepressant treatment and develop treatment-resistant conditions.

There is a definitive need for rapid-acting, effective treatments. Developing and creating access to groundbreaking treatments is key, and one such new treatment option is intravenous (IV) ketamine.

Pasithea Clinics is determined to flip the script on recovery options for people with depression, anxiety and PTSD whose illnesses don’t respond well to traditional antidepressants.The company’s plan is to enable doctors to provide access to IV ketamine infusions in mental health clinics in the U.K.